This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Head and Neck Cancer
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

Patients with advanced head and neck cancer is at high risk of recurrence at the primary site or in the neck. Part of normal treatment is to treat such patients with chemotherapy and radiation. The chemotherapy can include Erbitux. The purpose of this study is to treat such patients with an additional agent, Torisel. This study tests the doses of Torisel that can be safely administered together with radiation and chemotherapy.

Provided treatments

  • Drug: Temsirolimus
  • Drug: Cetuximab
  • Drug: Cisplatin
  • Device: Radiation Therapy

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01326468. The sponsor of the trial is Sidney Kimmel Cancer Center at Thomas Jefferson University and it is looking for 0 volunteers for the current phase.
Official trial title:
A Pilot Study of Chemoradiotherapy Plus Temsirolimus (Torisel) for Advanced Head and Neck Cancer